SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030405
Filing Date
2019-08-08
Accepted
2019-08-08 07:01:39
Documents
96
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q reph-10q_20190630.htm 10-Q 2399225
2 EX-31.1 reph-ex311_8.htm EX-31.1 17405
3 EX-31.2 reph-ex312_6.htm EX-31.2 17335
4 EX-32.1 reph-ex321_7.htm EX-32.1 8570
  Complete submission text file 0001564590-19-030405.txt   10562710

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT reph-20190630.xml EX-101.INS 2551568
6 XBRL TAXONOMY EXTENSION SCHEMA reph-20190630.xsd EX-101.SCH 81600
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reph-20190630_cal.xml EX-101.CAL 71628
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reph-20190630_def.xml EX-101.DEF 268573
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20190630_lab.xml EX-101.LAB 610171
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20190630_pre.xml EX-101.PRE 476928
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 191007411
SIC: 2834 Pharmaceutical Preparations